Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects

被引:72
作者
Huang, Hsien-Liang
Lin, Wen-Yuan
Lee, Long-Teng
Wang, Hsih-Hsi
Lee, Wei-Jei
Huang, Kuo-Chin
机构
[1] Natl Taiwan Univ Hosp, Dept Family Med, Taipei 100, Taiwan
[2] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan
[3] Ever Hlth Clin, Taipei, Taiwan
[4] Ming Shen Hosp, Dept Surg, Taipei, Taiwan
关键词
metabolic syndrome; steatohepatitis; high fasting glucose; high blood pressure; adiponectin; morbid obesity;
D O I
10.1007/s11695-008-9423-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Metabolic syndrome (MetS) and nonalcoholic fatty liver disease (NAFLD), ranging from simple steatosis to steatohepatitis (NASH), have become important health issues in obese subjects. In this study, we investigated the relationship between MetS and NASH in severely obese subjects. Methods: A total of 111 non-alcoholic obese patients who underwent laparoscopic bariatric surgery (BMI 45.4 +/- 5.7 kg/m(2)) were enrolled from February to September 2004 in a referral center in North Taiwan. MetS and its individual components were defined using the American Heart Association/National Heart, Lung, and Blood Institute criteria. Based on liver biopsy during surgery, subjects were classified into either having NASH or not. The relationship among NASH, adiponectin, insulin resistance, MetS and its individual components was examined using a multivariate logistic regression analysis. Results: The prevalence of NASH and MetS in these subjects was 79.3% and 68.5%, respectively. Using a multivariate logistic regression analysis with NASH as the outcome variable, odds ratio (OR) of NASH for subjects with MetS versus without MetS was 2.96 (95% Cl= 1.14-7.68) adjusted for age, gender, and BMI. Also, high blood pressure (OR= 2.97, 1.31-6.73) and high fasting glucose (OR= 2.94, 1.13-7.67) were independently associated with NASH after adjustment for age, gender, and BMI. Insulin resistance measured as HOMA-IR and serum adiponectin level were not significantly different between the NASH and non-NASH group. Conclusion: MetS and NASH were common in severely obese Taiwanese adults. Presence of MetS, high blood pressure, and high fasting glucose was independently related to increased risk of NASH. The underlying mechanism deserves to be explored in the future.
引用
收藏
页码:1457 / 1463
页数:7
相关论文
共 43 条
[1]
Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease [J].
Abrams, GA ;
Kunde, SS ;
Lazenby, AJ ;
Clements, RH .
HEPATOLOGY, 2004, 40 (02) :475-483
[2]
The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women [J].
Arun, Janani ;
Clements, Ronald H. ;
Lazenby, Audrey J. ;
Leeth, Ruth R. ;
Abrams, Gary A. .
OBESITY SURGERY, 2006, 16 (10) :1351-1358
[3]
Ubiquitin as a marker of cell Injury in nonalcoholic steatohepatitis [J].
Banner, BF ;
Savas, L ;
Zivny, J ;
Tortorelli, K ;
Bonkovsky, HL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (06) :860-866
[4]
Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3
[5]
Adipose tissue, inflammation, and cardiovascular disease [J].
Berg, AH ;
Scherer, PE .
CIRCULATION RESEARCH, 2005, 96 (09) :939-949
[6]
Medical consequences of obesity [J].
Bray, GA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2583-2589
[7]
Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions [J].
Brunt, EM ;
Janney, CG ;
Di Bisceglie, AM ;
Neuschwander-Tetri, BA ;
Bacon, BR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) :2467-2474
[8]
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638
[9]
Low body mass index but high percent body fat in Taiwanese subjects: implications of obesity cutoffs [J].
Chang, CJ ;
Wu, CH ;
Chang, CS ;
Yao, WJ ;
Yang, YC ;
Wu, JS ;
Lu, FH .
INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (02) :253-259
[10]
Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]